Eli Lilly and Company, headquartered in Indianapolis, Indiana, is one of the world's leading pharmaceutical companies, known for its innovative research and development in medicines. Founded in 1876 by Colonel Eli Lilly, the company has a rich history of discovering, developing, and delivering breakthrough treatments for some of the most challenging diseases. Eli Lilly focuses on creating life-saving and life-enhancing medications in areas such as oncology, diabetes, immunology, and neuroscience.
With a commitment to advancing healthcare, Eli Lilly consistently invests in research and cutting-edge technologies to bring new treatments to market. The company operates in over 120 countries, employing more than 35,000 people globally. Their mission is to improve patient outcomes and quality of life by providing innovative healthcare solutions.
CEO and Founder of Eli Lilly
Eli Lilly was founded in 1876 by Colonel Eli Lilly, a pharmaceutical chemist and Civil War veteran, with the goal of developing high-quality medicines. His vision was to establish a company that adhered to scientific rigor and ethics, which became the foundation of Eli Lilly’s global success.
Currently, David A. Ricks serves as the Chairman and CEO of Eli Lilly. He has been with the company for over two decades, rising through the ranks with a focus on driving growth through innovation and expanding Eli Lilly’s global footprint. Under his leadership, Eli Lilly has strengthened its position in key therapeutic areas and continued to deliver groundbreaking treatments that address unmet medical needs.
List of Top Companies Under Eli Lilly (USA)
Eli Lilly, through strategic acquisitions and partnerships, has expanded its influence across the pharmaceutical and healthcare industries. Below is a list of some notable companies and subsidiaries under Eli Lilly, along with their estimated valuations:
| Company Name | Year Acquired/Founded | Valuation | Industry |
|---|---|---|---|
| Loxo Oncology | 2019 (Acquired) | $8 Billion | Oncology and Cancer Treatment |
| Dermira, Inc. | 2020 (Acquired) | $1.1 Billion | Dermatology and Immunology |
| Prevail Therapeutics | 2021 (Acquired) | $1 Billion | Gene Therapy for Neurodegenerative Diseases |
| ImClone Systems | 2008 (Acquired) | $6.5 Billion | Biopharmaceuticals, Cancer Therapies |
| CoLucid Pharmaceuticals | 2017 (Acquired) | $960 Million | Migraine Treatment (Lasmiditan) |
| ARMO BioSciences | 2018 (Acquired) | $1.6 Billion | Immuno-Oncology |
| Disarm Therapeutics | 2020 (Acquired) | $1.35 Billion | Neurology (ALS, Multiple Sclerosis) |
| Akouos | 2022 (Acquired) | $487 Million | Gene Therapy for Hearing Loss |
| Avid Radiopharmaceuticals | 2011 (Acquired) | $300 Million | Imaging Diagnostics for Alzheimer’s |
FAQs About Eli Lilly (USA)
Q1: When was Eli Lilly founded, and by whom?
A: Eli Lilly was founded in 1876 by Colonel Eli Lilly, a pharmaceutical chemist and former military officer, with a mission to produce high-quality medications.
Q2: Who is the current CEO of Eli Lilly?
A: David A. Ricks is the current Chairman and CEO of Eli Lilly. He has been with the company since 1996 and took over as CEO in 2017.
Q3: What are Eli Lilly’s key therapeutic areas?
A: Eli Lilly focuses on oncology, diabetes, immunology, and neuroscience, offering innovative treatments for cancer, diabetes, autoimmune diseases, and mental health disorders.
Q4: What are some major companies acquired by Eli Lilly?
A: Some of the notable acquisitions by Eli Lilly include Loxo Oncology, Dermira, ImClone Systems, Prevail Therapeutics, and ARMO BioSciences.
Q5: What is Eli Lilly’s global presence?
A: Eli Lilly operates in over 120 countries and employs more than 35,000 people worldwide, with a strong focus on research and development.
Q6: What are some major innovations by Eli Lilly?
A: Eli Lilly has been at the forefront of medical innovation, bringing to market life-changing medications such as insulin for diabetes, Alimta for lung cancer, and Emgality for migraines.
